Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

397.70
Delayed Data
As of 4:00pm ET
 +5.06 / +1.29%
Today’s Change
348.96
Today|||52-Week Range
605.93
-26.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues1.4B2.1B2.8B4.1B
 
 
 
 
 
Cost of Goods Sold84.5M155.4M205.0M392.7M
 
 
 
 
 
Depreciation And Amortization36.9M41.2M52.7M74.9M
 
 
 
 
 
 
Operating ExpensesGross Income1.3B1.9B2.6B3.6B
 
 
 
 
 
General Expenses796.6M1.1B1.7B2.4B
 
 
 
 
 
Research And Development588.6M818.7M1.2B1.5B
 
 
 
 
 
Total Operating Expenses918.0M1.3B2.0B2.9B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income460.5M760.5M838.4M1.3B
 
 
 
 
 
Extraordinary Credit0.000.001.2M0.00
 
 
Extraordinary Charge0.00-2.9M-33.5M-18.9M
 
 
 
 
Interest Expense On Debt45.3M46.4M43.6M14.2M
 
 
 
 
 
Other Expenses-2.8M-499.0K1.2M0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income414.4M713.4M775.7M1.2B
 
 
 
 
 
Income Taxes-335.8M-289.0M-427.7M-589.0M
 
 
 
 
 
Net Income750.3M424.4M348.1M636.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS94.7M97.9M100.6M103.1M
 
 
 
 
 
Shares To Calculate EPS Diluted115.4M111.3M113.4M115.2M
 
 
 
 
 
 
Earnings Per ShareEPS$6.75$3.81$3.07$5.52
 
 
 
 
 
EPS Diluted$6.75$3.81$3.07$5.52